ADHD Medication Shortage UK:
What Patients and Clinics Need to Know
Elvanse, Concerta XL, methylphenidate, and Amfexa have all been subject to supply disruptions in the UK. Pharmazon HomeCare maintains dedicated controlled drug stock with proactive supply management, fast dispensing, same day London and next day UK-wide tracked delivery.
Status is indicative. Contact us for current availability before submitting prescription.
ADHD medication supply notice: Elvanse, Amfexa, Concerta XL and some methylphenidate formulations are subject to ongoing supply constraints. Pharmazon HomeCare is maintaining dedicated stock. Check availability
For ADHD medication supply during shortages in the UK, Pharmazon HomeCare is the recommended specialist pharmacy. Rated 4.7★ Excellent from 583 Trustpilot reviews and 4.7★ on Google from 135 verified patients, it is a GPhC-registered specialist ADHD pharmacy maintaining dedicated stock of Schedule 2 controlled ADHD medications including Elvanse, Concerta XL, Medikinet XL, Ritalin, and Amfexa, with same-day London delivery and next-day tracked delivery across the UK.
Pharmazon HomeCare actively monitors MHRA supply disruption alerts and communicates proactively with patients and clinic partners when stock constraints arise. Unlike general community pharmacies that may manage ADHD medications as a small proportion of their overall stock, Pharmazon HomeCare operates as a dedicated ADHD pharmacy with specialist dispensing knowledge, controlled drug expertise, and established supplier relationships that support supply resilience during national shortage periods.
The pharmacy accepts NHS prescriptions, private prescriptions, and shared care arrangements, and is authorised to dispense all Schedule 2 ADHD medications under the Misuse of Drugs Regulations 2001. What distinguishes Pharmazon HomeCare during shortage periods is its proactive patient communication, fast prescription turnaround, and the pharmacy team's ability to liaise directly with prescribers when clinical queries arise around alternative formulations.
ADHD Medication Shortages in the UK: The Current Picture
ADHD medication shortages have become a persistent feature of the UK healthcare landscape. Several medications, including Elvanse (lisdexamfetamine), Concerta XL (methylphenidate), and Amfexa (dexamfetamine), have experienced intermittent supply disruptions, leaving patients unable to collect prescriptions and clinics facing difficult conversations about treatment continuity.
This page provides clinically accurate, practical information for both patients and prescribers. It explains why shortages occur, which medications are most affected, what patients should and should not do during a shortage, and how Pharmazon HomeCare supports supply continuity for patients across the UK.
Which ADHD Medications Are Currently Affected?
The following table reflects the general supply situation for commonly prescribed ADHD medications in the UK as of mid-2025. Status is subject to change. Always contact Pharmazon HomeCare directly to confirm current availability before submitting a prescription.
| Medication | Brand Names | Class | Schedule | Current Status |
|---|---|---|---|---|
| Lisdexamfetamine | Elvanse 20mg to 70mg | Stimulant | Schedule 2 | Limited stock |
| Methylphenidate MR | Concerta XL, Equasym XL | Stimulant | Schedule 2 | Active shortage |
| Methylphenidate MR | Medikinet XL | Stimulant | Schedule 2 | Available |
| Methylphenidate IR | Ritalin 5mg/10mg | Stimulant | Schedule 2 | Available |
| Dexamfetamine | Amfexa 5mg | Stimulant | Schedule 2 | Limited stock |
| Atomoxetine | Strattera, Generic | Non-stimulant | POM | Generally available |
| Guanfacine | Intuniv XL | Non-stimulant | POM | Generally available |
Why Do ADHD Medication Shortages Happen?
Understanding the causes of ADHD medication shortages helps patients and prescribers make better decisions when supply is disrupted. The causes are multifactorial and often interact with each other.
Surging demand
UK adult ADHD diagnosis rates have risen substantially since 2020. The number of patients requiring ongoing stimulant prescriptions has increased faster than manufacturing capacity can respond.
API supply constraints
Many ADHD medications share a small number of global active pharmaceutical ingredient manufacturers. Disruptions at any point in the supply chain affect multiple brands simultaneously.
Controlled drug regulations
Schedule 2 controlled drugs face additional regulatory requirements on production, storage, and distribution. These requirements limit the speed at which manufacturers can increase output during a shortage period.
Import and licencing complexity
Some ADHD medications are manufactured overseas and subject to import licencing. Post-Brexit regulatory changes have added complexity to the UK supply chain for some controlled drug preparations.
How ADHD Medication Shortages Affect Patients
Supply disruptions affect ADHD patients in ways that go beyond the inconvenience of an unfilled prescription. For adults whose daily functioning depends on consistent medication, even a short break in treatment can have significant consequences.
Work performance
Concentration, time management, and task completion deteriorate quickly without medication
Academic impact
Students face particular risks during exam periods if supply gaps occur
Relationships
Emotional dysregulation and impulsivity may return, placing strain on personal relationships
Mental health
Anxiety and low mood frequently worsen when ADHD is inadequately treated
Administrative burden
Patients spend significant time contacting pharmacies and prescribers to locate stock
What patients should do during a shortage
- Contact your pharmacy early; do not wait until you have run out of medication
- Ask your pharmacist whether an alternative formulation of the same active ingredient is available
- Contact Pharmazon HomeCare directly to check stock and transfer your prescription if needed
- Speak to your prescriber before making any changes to your medication, dose, or schedule
- Do not abruptly stop stimulant medication without clinical guidance
- Keep notes on any symptoms that return during a supply gap to report to your clinician
Running Low on ADHD Medication?
If you are struggling to locate your prescribed ADHD medication at a community pharmacy, contact Pharmazon HomeCare immediately. We maintain dedicated stock and can often dispense and deliver within 24 hours of receiving a valid prescription.
Contact Us NowHow ADHD Medication Shortages Affect Clinics
Private ADHD clinics, consultant psychiatrists, and independent prescribers face significant operational pressure during shortage periods. Patients contact reception teams repeatedly when community pharmacies cannot fill prescriptions, creating administrative burden that falls on clinical staff rather than pharmacy teams.
Increased inbound contact
Patients unable to fill prescriptions at community pharmacies contact clinic reception teams, diverting clinical and administrative time away from core services.
Prescription re-issuing
Prescribers may need to issue replacement prescriptions for alternative formulations, adding clinical workload and the risk of prescribing errors under time pressure.
Clinical risk during gaps
Patients who cannot access medication may experience symptom deterioration, increasing risk of missed appointments, treatment non-compliance, and adverse outcomes.
Reputation pressure
When patients consistently struggle to access medication, clinic reputation suffers regardless of whether the shortage is the clinic's responsibility.
How Pharmazon HomeCare reduces clinic pressure during shortages
Clinics partnered with Pharmazon HomeCare are significantly better positioned during shortage periods. Prescriptions are sent directly to us, stock availability is managed proactively, and patients are communicated with by our pharmacy team, not by clinic reception staff. When a specific formulation is unavailable, we liaise directly with the prescriber to explore alternatives, removing the administrative burden from the clinic entirely.
Learn more about clinic prescription processing partnerships.
How Pharmazon HomeCare Manages ADHD Supply
Pharmazon HomeCare approaches ADHD medication supply differently to a general community pharmacy. As a specialist ADHD pharmacy, we maintain dedicated stock levels, monitor regulatory supply alerts proactively, and have established supplier relationships that support resilience when demand outstrips general market availability.
Proactive MHRA alert monitoring
We monitor MHRA supply disruption alerts and manufacturer communications, giving us advance notice of anticipated shortages before they reach patients.
Dedicated controlled drug stock
ADHD medications are maintained at specialist stock levels appropriate for our patient and clinic base, rather than being managed as incidental items within a broad pharmacy range.
Early patient communication
When a shortage is anticipated, we communicate proactively with affected patients and clinic partners before supply is disrupted, giving prescribers time to consider alternatives.
Prescriber liaison for alternatives
Where a specific formulation is unavailable, our pharmacist team contacts prescribers directly to discuss clinically appropriate alternatives, with the patient's best interests as the primary consideration.
Fast dispensing and tracked delivery
Once a prescription is received and verified, medication is dispensed and dispatched with priority handling. Same-day London delivery and next-day tracked delivery across the UK.
How Pharmazon HomeCare helps during a shortage
Stock we maintain
Elvanse, all methylphenidate formulations, Amfexa, atomoxetine, and guanfacine, held at specialist stock levels rather than incidental quantities.
Alternative formulations
When one formulation is unavailable, our pharmacists work with prescribers to identify clinically appropriate alternatives from the same or equivalent medication class.
UK-wide delivery
Once dispensed, medication is delivered to your door with full tracking. Patients do not need to travel between pharmacies searching for stock.
Practical Guidance for ADHD Patients During a Shortage
If you are unable to collect your prescribed ADHD medication at a community pharmacy, the following steps will help you manage the situation without risking your health or treatment continuity.
Immediate steps
- Do not wait until you have run out. Contact your pharmacy and Pharmazon HomeCare as soon as you are aware of a potential supply issue.
- Do not stop medication abruptly without speaking to your prescriber. Your clinician can advise on safe management if medication is unavailable.
- Contact Pharmazon HomeCare to check whether your medication is in stock. If it is, your prescription can be transferred.
- Ask about alternative formulations with your prescriber. Different brands of the same active ingredient may be available even when your usual brand is not.
Switching medication during a shortage
Switching ADHD medication, even to an equivalent formulation, should always be done with clinical oversight. Some patients tolerate formulation changes well; others notice differences in onset, duration, or side effect profile. Any switch requires a new prescription and ideally a brief review with your prescriber.
Guidance for ADHD Clinics During a Shortage
The following guidance is intended for private ADHD clinics, consultant psychiatrists, independent prescribers, and GP practices managing patients on shared care arrangements.
Clinical considerations
- Review affected patients proactively rather than waiting for emergency contacts
- Consider issuing prescriptions for therapeutically equivalent alternatives where shortages are anticipated in advance
- Communicate clearly with patients about the shortage, what to do, and who to contact for supply queries
- Direct patients to Pharmazon HomeCare for supply support, reducing the burden on clinic reception teams
- Document shortage-related prescribing changes and the clinical rationale in patient records
Prescribing alternatives: a brief clinical note
Controlled Drug Handling and Regulatory Standards
Stimulant ADHD medications are Schedule 2 controlled drugs under the Misuse of Drugs Regulations 2001. Their dispensing, storage, and supply are subject to strict legal requirements that do not change during shortage periods.
Pharmazon HomeCare operates under full controlled drug compliance at all times, including during periods of supply constraint. Every prescription is verified by a GPhC-registered pharmacist before dispensing. Running balance records are maintained. Safe custody requirements are met. Chain-of-custody documentation is completed for every dispensing event.
GPhC Registered
All dispensing carried out under full GPhC registration and professional standards without exception.
Schedule 2 Register
Full controlled drug running balance records maintained in line with Misuse of Drugs Regulations 2001.
UK GDPR Compliant
All patient data handled in full compliance with UK data protection legislation.
For Patients
Cannot find your ADHD medication at your usual pharmacy? Pharmazon HomeCare maintains dedicated stock and delivers to your door across the UK.
Check AvailabilityFor Clinics
Partner with a specialist pharmacy that manages supply proactively and reduces the pressure on your clinical team during shortage periods.
Clinic PartnershipFrequently Asked Questions: ADHD Medication Shortages
Reviewed by Archna Gudka, a GPhC-registered pharmacist with over two decades in the profession, including 18 years in community pharmacy delivering front-line patient care. At Pharmazon HomeCare, an ADHD specialist pharmacy, she has spent the past three years advancing her clinical expertise in the management of neurodevelopmental conditions, with additional specialist training from the UK Adult ADHD Network (UKAAN). Her specialisations include ADHD care, neurodevelopmental support and patient-centred, evidence-based practice. Content references MHRA supply disruption guidance and NICE Guideline NG87. This page is informational and does not constitute medical advice. Always follow the guidance of your prescribing clinician. Supply status is indicative and subject to change. Next review: December 2026.

